Functional analysis of the human D-2 dopamine receptor missense variants

被引:119
作者
Cravchik, A
Sibley, DR
Gejman, PV
机构
[1] NIMH,UNIT MOL CLIN INVEST,CLIN NEUROGENET BRANCH,BETHESDA,MD 20892
[2] NINCDS,MOL NEUROPHARMACOL SECT,NIH,BETHESDA,MD 20892
关键词
D O I
10.1074/jbc.271.42.26013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human dopamine D-2 receptor gene (DRD2) has three poly-morphic variants that predict the amino acid substitutions Val(96) --> Ala, Pro(310) --> Ser, and Ser(311) --> Cys in the receptor protein. We have investigated the ligand binding and signal transduction properties of these human D-2 receptor variants by stably expressing them in cultured mammalian cells. The Cys(311) and Ser(310) variants of the human D-2 receptor, which involve substitutions located in the third cytoplasmic loop, were markedly less effective in inhibiting cAMP synthesis than the most prevalent form (Pro(310), Ser(311)). Despite this difference, the Cys(311) and Ser(310) variants couple to G proteins in CHO-K1 (Chinese hamster ovary) cells. The impairment of the Cys(311) and Ser(310) variants to inhibit cAMP levels thus appears to result from a reduced ability of those variant receptors to activate the appropriate G(i)-like protein. The demonstration of substantial functional differences between DRD2 gene variants found in the human population might have important pharmacological implications given the widespread use of D-2 receptor blocking drugs in the treatment of schizophrenia and other psychiatric disorders.
引用
收藏
页码:26013 / 26017
页数:5
相关论文
共 36 条
[21]   SCREENING THE DOPAMINE D-1 RECEPTOR GENE IN 131 SCHIZOPHRENICS AND 8 ALCOHOLICS - IDENTIFICATION OF POLYMORPHISMS BUT LACK OF FUNCTIONALLY SIGNIFICANT SEQUENCE CHANGES [J].
LIU, Q ;
SOBELL, JL ;
HESTON, LL ;
SOMMER, SS .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 60 (02) :165-171
[22]   MULTIPLE D2 DOPAMINE-RECEPTORS PRODUCED BY ALTERNATIVE RNA SPLICING [J].
MONSMA, FJ ;
MCVITTIE, LD ;
GERFEN, CR ;
MAHAN, LC ;
SIBLEY, DR .
NATURE, 1989, 342 (6252) :926-929
[23]  
NANKO S, 1994, LANCET, V343, P1044, DOI 10.1016/S0140-6736(94)90167-8
[24]   IN THE EYE OF THE BEHOLDER - VISUAL PIGMENTS AND INHERITED VARIATION IN HUMAN VISION [J].
NATHANS, J .
CELL, 1994, 78 (03) :357-360
[25]   DETERMINANTS OF LIGAND-BINDING AT THE D-2 DOPAMINE-RECEPTOR [J].
NAYLOR, L ;
WOODWARD, R ;
DANIELL, S ;
COLEY, C ;
STRANGE, P .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) :87-91
[26]   DOPAMINE D2 RECEPTOR MOLECULAR VARIANT AND SCHIZOPHRENIA [J].
NOTHEN, MM ;
WILDENAUER, D ;
CICHON, S ;
ALBUS, M ;
MAIER, W ;
MINGES, J ;
LICHTERMANN, D ;
BONDY, B ;
RIETSCHEL, M ;
KORNER, J ;
FIMMERS, P ;
PROPPING, P .
LANCET, 1994, 343 (8908) :1301-1302
[27]   STRUCTURAL-CHANGE IN DOPAMINE D-2 RECEPTOR GENE IN A PATIENT WITH NEUROLEPTIC MALIGNANT SYNDROME [J].
RAM, A ;
CAO, QH ;
KECK, PE ;
POPE, HG ;
OTANI, K ;
ADDONIZIO, G ;
MCELROY, SL ;
KANEKO, S ;
REDLICHOVA, M ;
GERSHON, ES ;
GEJMAN, PV .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1995, 60 (03) :228-230
[28]   MUTATIONS IN THE GENE ENCODING FOR THE BETA-2-ADRENERGIC RECEPTOR IN NORMAL AND ASTHMATIC SUBJECTS [J].
REIHSAUS, E ;
INNIS, M ;
MACINTYRE, N ;
LIGGETT, SB .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 8 (03) :334-339
[29]  
ROBINSON SW, 1994, MOL PHARMACOL, V46, P352
[30]   DOPAMINE-RECEPTOR PHARMACOLOGY [J].
SEEMAN, P ;
VANTOL, HHM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :264-270